Unintended Consequences of Opioid Regulations in Older Adults with Multiple Chronic Conditions

Christine S Ritchie1, Sarah B Garrett2,3, Nicole Thompson4

  • 1The Mongan Institute and the Division of Palliative Care and Geriatric Medicine, Massachusetts General Hospital, Boston.

The Gerontologist
|March 31, 2020
PubMed
Abstract

Insights

The opioid epidemic and policy changes negatively impacted older adults with chronic pain and multiple chronic conditions (MCC), affecting their pain management and patient-clinician relationships. Understanding these experiences is crucial for improving care.

Area of Science:

  • Gerontology
  • Public Health
  • Pain Management

Background:

  • The opioid epidemic has prompted significant regulatory and policy shifts.
  • Impacts on older adults with chronic pain and multiple chronic conditions (MCC) remain under-researched.
  • Understanding these experiences is vital for informed healthcare policy.

Purpose of the Study:

  • To explore the lived experiences of older adults with chronic pain and MCC.
  • To examine the influence of the opioid epidemic and related policies on their pain management.
  • To identify unintended consequences and patient concerns.

Main Methods:

  • Qualitative study utilizing semistructured in-depth interviews.
  • Purposive sampling of 25 adults aged 65+ with chronic pain and MCC.
  • Constant comparative method for thematic analysis of transcribed interviews.

Main Results:

  • Four key themes emerged: altered patient-clinician relationships, reduced patient agency in pain management, ambivalence/anxiety regarding opioid use, and future concerns.
  • Policy responses to the opioid crisis have had unintended negative consequences for this population.
  • Patients reported challenges in accessing and managing pain effectively.

Conclusions:

  • Older adults with chronic pain and MCC face unique challenges exacerbated by the opioid epidemic.
  • Policy interventions must consider the specific needs and vulnerabilities of this demographic.
  • Clinicians should prioritize patient-clinician communication, empowerment, and addressing patient anxieties to mitigate negative impacts.

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
168
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
169
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
141
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
823
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
756
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.4K